Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agreed - when it dipped today but could not fall below prior day close, it showed a lot of strength. I would not be shocked by a flat day tomorrow and then larger moves Friday and Monday, but I don't see a dip now. I called $1.28 before open this morning, and still think that is a good call for today's close.
If you think the price is out of whack, short it
I don't care about fundamentals on this - just a momentum trade for me. If it is trending up, I buy it with a tight stop. Worked well so far.
If I had to guess, I would say it is over-priced, but I feel that way about 99% of stocks.
Thanks - I will add SOL to my watch list (only reason I did not was b/c it lagged behind the others in the 1-year recovery, but that may actually be good as it may have more room to run).
I don't hold any of them right now - watch DQ closely. After its predictable morning fall after a 60% run, it is holding up really strong. I will considering picking up some solars EOD.
Not yet.
Focus on the trading cashflow/PR/set-up and put the pieces together from there. Remember, the best promos don't show up on all the promo tracking sites until the last stage of the run.
I took a quick look at the solars. Seems to me that JKS and HSOL are the best ones to watch with DQ. For an interesting chart, through them all in google finance and look at the 5 year comparable with all 3. Comparison suggest HSOL has room to move up. JKS has perfomed the best, followed by DQ. DQ and HSOL.
CSUN, YGE and TSL are also interesting to follow.
NNVC uplists today - I had traded this one in the past and didn't even notice this new until this morning. Should be interesting. Of the last 2, ONVO popped nice and CRRS crashed, so I suggest waiting until at least 10AM to see what the trend is if you trade this puppy.
------
NanoViricides to List Common Stock on New York Stock Exchange MKT; Company Stock Symbol Will Remain NNVC
Date : 09/23/2013 @ 7:00AM
Source : Business Wire
Stock : NanoViricides, Inc. (NNVC)
Quote : 0.92 0.0 (0.00%) @ 2:05AM
NanoViricides to List Common Stock on New York Stock Exchange MKT; Company Stock Symbol Will Remain NNVC
Print
Alert
NanoViricides, Inc. (USOTC:NNVC)
Historical Stock Chart
1 Month : From Aug 2013 to Sep 2013
Click Here for more NanoViricides, Inc. Charts.
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company") is pleased to announce that its common shares have been approved to list on the NYSE MKT (the “Exchange”) and will begin trading on the New York Stock Exchange on Wednesday, September 25, 2013. The Company will continue to trade under the symbol "NNVC". In connection with this listing, NanoViricides’ common stock will cease trading on the OTC BB.
“Trading on NYSE-MKT is an important milestone for us,” said Anil R. Diwan, PhD, President of the Company, adding, “In order to deliver maximum benefit for our shareholders, we decided that listing on a National Exchange was very important. We then determined that NYSE MKT provides an ideal combination of Company Requirements and Market Regulatory Policies that would be of great benefit to development stage biopharma companies such as ours. We are happy to be part of the NYSE MKT community. With a rich platform technology that has already yielded six commercially important drug candidates, we are very excited to move towards human clinical trials, and look forward to a great future on the Exchange.”
NYSE MKT is considered a premier US equities market for listing and trading of small growth companies. NYSE MKT is a fully integrated trading venue within the NYSE Euronext community and leverages the NYSE's advanced and innovative market model to offer a premier venue for listing and trading the stocks of small companies. The venue utilizes the trading, connectivity and routing technologies of the NYSE platform and offers superior price discovery, superior liquidity and reduced trading volatility. Listed companies benefit from issuer-selected Designated Market Makers (DMM) that utilize world-class NYSE trading systems to discover and improve prices, dampen volatility, add liquidity and enhance value. In addition, NYSE MKT-listed companies gain access to the brand visibility and are eligible for the issuer services enjoyed by the NYSE Euronext community.
“We congratulate NanoViricides on their listing with NYSE MKT,” said Scott Cutler, Executive Vice President, Head of Global Listings, NYSE Euronext. “Our community ranges across a variety of industries and it is always exciting for a biotech company like NanoViricides to benefit from our platform and further support their research and development.”
“This move to the Exchange comes at a time when the Company is making excellent progress towards its goal of taking FluCide®, its broad-spectrum anti-influenza drug, into human clinical trials as soon as feasible,” said Eugene Seymour, MD, MPH, CEO of the Company, adding, “In addition, construction of the cGMP pilot manufacturing and R&D facility is proceeding on schedule. The Company now has over $22M in cash that is expected to enable us to complete the FluCide Phase I and II clinical trials. The Company plans to move DengueCide®, a drug for dengue/dengue hemorrhagic fever into human clinical trials following injectable FluCide. DengueCide is in advanced pre-clinical development stage and has already received an Orphan Drug designation from the US FDA. Following these, we also have Oral FluCide, HIVCide, HerpeCide, and EKCCide at various stages in preclinical development. We fully expect these drug candidates to enter human clinical trials, based on the strong effectiveness and safety we have seen so far. Together these drug candidates represent a market size of over $40 Billion. In addition, we know that as a good drug becomes available against a disease, the market size for it expands dramatically. We look forward to realizing the great potential of our Company as we list on the New York Stock Exchange MKT.”
The Company also announces that it has selected J. Streicher & Co., LLC as its Designated Market Maker on NYSE-MKT.
NanoViricides Pipeline
NanoViricides is developing broad-spectrum anti-influenza drugs as part of its rich drug pipeline. The Company believes that its FluCide™ drug candidates will be effective against most if not all influenza viruses, including the H7N9 bird flu, H3N2 or H1N1 epidemic viruses, H5N1 bird flu, seasonal influenzas, as well as novel influenza viruses. This is because FluCide is based on the Company’s biomimetic technology, mimicking the natural sialic acid receptors for the influenza virus on the surface of a nanoviricide® polymeric micelle. It is important to note that all influenza viruses bind to the sialic acid receptors, even if they rapidly mutate. The FluCide drug candidates have already shown strong effectiveness against H1N1 and H3N2 influenza viruses in highly lethal animal models. The injectable FluCide drug candidates have shown 1,000X greater viral load reduction as compared to oseltamivir (Tamiflu®), the current standard of care, in a highly lethal influenza infection animal model. The Company believes that these animal model results should translate readily into humans.
NanoViricides has also developed an oral drug candidate against influenza. This oral version is also dramatically more effective than TamiFlu in the animals given a lethal influenza virus infection. This oral FluCide may be the very first nanomedicine that is effective when taken by mouth.
In addition, NanoViricides has developed drug candidates against Dengue, HIV/AIDS, Herpes, and Ocular Viral Diseases that have shown strong effectiveness in relevant animal and/or cell culture models.
About NanoViricides:
NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide® class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others.
This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in pre-clinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products.
FDA refers to US Food and Drug Administration. EMA refers to the European Union’s office of European Medical Agency.
Nice quote from the NNRX 8-k describes how our world works (NNRX should have a good day today by the way IMO):
Shareholders should be aware that, according to SEC Release No. 34-29093, the market for penny stocks has suffered in recent years from patterns of fraud and abuse. Such patterns include (1) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (3) boiler room practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (4) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (5) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the resulting inevitable collapse of those prices and with consequent investor losses. Our management is aware of the abuses that have occurred historically in the penny stock market. Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical limitations to prevent the described patterns from being established with respect to our securities. The occurrence of these patterns or practices could increase the volatility of our share price.
Nice news this morning - lets see a $1.28 close.
My favourite quote from the 8-k:
Shareholders should be aware that, according to SEC Release No. 34-29093, the market for penny stocks has suffered in recent years from patterns of fraud and abuse. Such patterns include (1) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (3) boiler room practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (4) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (5) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the resulting inevitable collapse of those prices and with consequent investor losses. Our management is aware of the abuses that have occurred historically in the penny stock market. Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical limitations to prevent the described patterns from being established with respect to our securities. The occurrence of these patterns or practices could increase the volatility of our share price.
I had picked it up Friday when I posted about it. Funny, I thought it was a mistake Monday when it gaped down a little and traded sideways, but then today it exploded. I agree this one will have opportunities over the next little while. I expect a retrace before the next move up, but if it starts trending up again like today, I may pick some up with a tight stop and a smaller target.
I agree. When I said $1.49, that is my target for my core position. I will continue to trade NNRX if we pass that PPS, I just won't hold it throughout the day anymore.
With respect to the tout below, as you all know, I have been trading NNRX and generally agree with the comments. Penny Stock Blog is just piggy-backing this one. The rumour is it is a Brighton play (GNIN, TALK). I suggest looking at the TALK chart for the potential moves of this one (back during its big run, of course). I like NNRX, but remember any of these promo tickers can crumble fast if someone starts dumping too many shares and the insiders decide to no longer support (see MEDA, which was much weaker than NNRX, but still shows what can happen). I think NNRX may hit $2 - my target is $1.49.
-------------
Penny Stock Experts Blog - blog.todayspickis.com
NNRX Closes Up 12.75% On The First Day Of Our Alert!
SIGN UP FOR OUR FREE PENNY STOCK NEWSLETTER ABOVE TO RECEIVE THE HOTTEST PENNY STOCK ALERTS BEFORE ANYONE ELSE!
Hi Everyone & Welcome New Subscribers,
Our new pick NNRX is off to a great start already, and with the action we're seeing, it will remain on top of our list all week long.
NNRX - Nutranomics, Inc. - closed up 12.75%, with 2.23 million shares traded, at $1.15 per share today.
NNRX is a publicly traded company engaged in research and development of nutritional food products. Nutranomics' mission is to increase human health and longevity through education and self-awareness.
As noted in our initial alert this morning, NNRX announced yesterday the appointment of Mr. Amar Chandnani to the newly created position of VP of Sales for South East Asia.
Read yesterday's entire press release, HERE.
Is this just the start of positive events to be announced by NNRX?
The way NNRX is trading certainly seems to suggest that may be more likely than not right now.
NNRX is on close watch for more news this week that could continue to propel the share price higher.
The time to look at NNRX is now before a potential swarm of new investors jump in!
Keep NNRX on top of your list again for tomorrow.
NNRX remains on HIGH ALERT!
Happy Trading!
The Penny Stock Experts Team at Todayspickis.com
Well, we both know they don't all work out good so I never like to overly tout a ticker. I never expected a move like that - got lucky to be honest. I will start following that ticker closely now though - it was an NYSE 10-bagger this year. Funny, it is a solar ticker - I recall you an I discussed months ago that we should put together a solar watch list. I will start watching solar again now. Also note that the shippers showed a sign that they may start another run - look at DRYS PM for confirmation. Then, FREE could be a fun one again.
I don't have a suggested PPS. I like to buy in EOD on this one. If I was not in yet, I would follow the 10AM rule (if PPS at 10 is below opening gapup, I would wait until the PPS climbs over the morning gapup before buying and would not buy if it does not).
Well done. I have not traded the tickers (other than BAC) that you mentioned. I am going to look into them.
Yeah, the 60% gain today seems too strong to hold this fast, especially at this PPS. If it goes down steady, I would consider shorting it and then switching back long. I still can't believe I did not see this ticker until Friday with all the scans I do - this type of volatility on the NYSE is great.
I am back on this one as of EOD today. Looks like shippers ready to rally on leg 4. The shipping index still is yet to have a red day; wish we could flip a 3x ETF based on that index. As I posted before here when I was flipping FREE last week, I suggest following DRYS to gauge the movement of FREE.
http://www.dryships.com/pages/report.asp
Just saw FU up 20% again - will have to put that one back on watch. The shippers also showed signs that run 4 may be coming. Keep a close watch on them tomorrow. I follow DRYS to gauge the group, and trade FREE the most if the shippers rally.
I sold it 30% up today and left a lot on the table - incredible move today. I also sold QRM too early today - not sure if I posted that one here. Been a good week for me between MEDA and VPIG bounces, NNRX promo, and DQ and QRM. I really like AMEX movers - they are nice and volatile.
Better keep an eye on DQ if you like Solar. After going up 60% today, should have a pull back, but it is a 10-bagger for the year and who knows how high it can go. And this is an NYSE ticker - not otc crap.
Thanks for your thoughts. I was just reading this board and saw you have been here a long time - smart man, incredible chart. I agree it looks overbought right now. I will have to keep this on my watch list permanently now though. After a pull back, it should run again. Love the low float. I am going to research this one in detail now. I only noticed it Friday because I picked it up on a scan - I had never heard of it before even though I have flipped solar tickers in the past. Love how the 52-week range is a 10-bagger; incredible for an NYSE listed ticker. Can't believe the short interest is so low - at first, I thought this was an USU type move, but that does not appear to be the case.
Funny - I posted this one on their board Friday also and was ignored; 60% later, guess they should have paid attention.
I suggested this one on my board Friday when I picked some up; first time I saw the ticker. Never thought it would do this well - 60% in one day on the big boards with no news; unbelievable. I sold when it was up 30% today and missed half the run - oh well. Do you think this will go much higher?
Anyone who checked out DQ as I suggested would be happy today - up 60%; and not even an OTC play
Many tickers have big 5-day runs with the last 2/3 at a high RSI
Speaking of bounces, MEDA also had a sweet intraday bounce from .47 - .70 - I called for this dip and rip last night, but missed this one as I was busy. Oh well. Will watch EOD to see if a trend develops - it is flat for the day.
Bounce I predicted on VPIG last night came faster than I thought- I caught a piece of it - ticker up 30% today
I think your wrong on that prediction - looks like we have a TALK V 2.0 here:
TALK
2013/05/13 1.80 2.05 1.80 1.98 9,131,546 1.98
2013/05/10 1.60 1.76 1.60 1.75 6,113,902 1.75
2013/05/09 1.45 1.56 1.39 1.56 3,890,095 1.56
2013/05/08 1.24 1.38 1.23 1.36 1,795,194 1.36
2013/05/07 1.24 1.30 1.20 1.24 1,625,956 1.24
2013/05/06 1.22 1.26 1.16 1.26 2,882,466 1.26
2013/05/03 1.09 1.16 1.07 1.14 1,341,241 1.14
2013/05/02 1.14 1.19 1.05 1.06 1,643,715 1.06
2013/05/01 1.03 1.15 1.02 1.14 2,308,478 1.14
2013/04/30 0.99 1.06 0.97 1.02 2,631,093 1.02
2013/04/29 0.93 0.99 0.89 0.98 3,734,912 0.98
2013/04/26 0.77 0.88 0.72 0.88 7,712,359 0.88
2013/04/25 0.61 0.70 0.61 0.70 25,000 0.70
I have not traded this one in what seems life forever in Penny Land. The easy money here was on the run up to the uplist; after that, it is a legit ticker with no volume that is not worth trading IMO. ONVO sure held up better than this one on the big boards. I had posted all along that I had taken profits on the run up and only held a small position by the time of the uplist. We all know the rules - trade the hype, sell the news.
Their own picks are unplayable, which makes it funny that they are trying to suggest this is one is theirs; every nickle and dime promo player knew about this one by yesterday morning.
It did follow the expected format this morning, and I did cash out some extra holdings on the predicable move up. I like to hold a core on these ones and then also swing trade larger dollar amounts on the side.
Penny Stock Experts Blog - blog.todayspickis.com
Our New Profiled Pick Is Nutranomics, Inc. - NNRX!
SIGN UP FOR OUR FREE PENNY STOCK NEWSLETTER ABOVE TO RECEIVE THE HOTTEST PENNY STOCK ALERTS BEFORE ANYONE ELSE!
Hi Everyone & Welcome New Subscribers,
Our new pick is NNRX - Nutranomics, Inc. - currently trading at $1.02 per share.
NNRX is a publicly traded company engaged in research and development of nutritional food products. Nutranomics' mission is to increase human health and longevity through education and self-awareness.
Just yesterday NNRX announced the appointment of Mr. Amar Chandnani to the newly created position of VP of Sales for South East Asia.
Read yesterday's entire press release, HERE.
We have a feeling this could just be the start of a string of positive events and announcements for NNRX, and don't expect it to last at this level for very long at all!
NNRX is on close watch for more positive news this morning, which could further support our theory that the stock is moving higher.
NNRX had a record day yesterday, closing just off yesterday's high, but we believe this is just the start and will be updating you as progress is reported over the next few weeks.
If the news released by NNRX continues to be received this well by investors, we could see the stock trading closer to $2.00 very soon!
Put NNRX on your radar immediately!
NNRX is on HIGH ALERT for today's trading!
Happy Trading!
The Penny Stock Experts Team at Todayspickis.com
Agreed - Penny Stock Blog is a d-lister. Got this one this morning:
PennyStocksForever.com does its best to bring you accurate information but errors may and sometimes do occur. Always do your own research before investing. PennyStocksForever.com is not a licensed financial advisor. This is a paid for marketing newsletter which will state compensation, if any, for the specific company being marketed in the disclaimer at the end of this newsletter, this is not a solicitation or recommendation to buy or sell securities. This is a paid advertisement.
Hi Everyone,
I will be releasing a Releasing a HUGE report this coming Thursday. Make sure you white list my email address and watch for my emails. My last alert moved up roughly 116%!
In the meantime, keep an eye on NNRX. It made a big move today after releasing a PR announcing their expansion into Asia. Big moves in higher priced stocks can usually indicate huge marketing campaigns and since this was the first day, this will be one to watch.
I was not paid to write this alert on NNRX and I don't own any stock in the company and don't intend to trade it. Remember quality over quantity.
A few of us have been trading MCZ - touts for that one and 2 others I will have to take a look at are discussed on gumshoe today:
“3 Undiscovered Stocks That Could Explode This Year!” from Penny Stock All-Stars
Where is Gordon Lewis looking for the "next Apple?"
Posted on September 23, 2013 by Travis Johnson, Stock Gumshoe
WP Greet Box icon
X
Welcome! If you are new to Stock Gumshoe, grab a free membership here and join us to get our free newsletter alerts with new teaser answers and debunkings. Thanks!
Not new? Please log in at top right of this page
With a name like “Penny Stock All-Stars“, you’d probably guess that you’re looking at a company that looks for huge gainers in tiny companies — and if you’re a relatively sober and thoughtful investor, you’ll also be pretty sure that this means that even a good newsletter in this category is likely to have a few flameouts for every 100%+ winner… the plan, among these small cap letters, is usually that the losers get cut off before they fall too dramatically (and therefore get nicely expunged from the published portfolio), and the few hopefully very large gainers (100%, 500%, 1,000% if you’re lucky) will more than make up for the losers.
I think I’ve only covered this small Penny Stock All-Starts newsletter once — the editor is Gordon Lewis, and we covered his teaser pitch for a few companies back in 2011. He kept running similar ads for quite a long time, touting the “next Dominos” and the “next Las Vegas Sands” … the pizza one turned out to be small regional pizza player Pizza Inn (PZZI), which is trying to bring a new “Pie Five” concept national and tripled this Spring but then came back and is now still a solid 100% gainer from when they wrote about it, the casino operator was Full House Resorts (FLL), which has also been pretty volatile but is now more or less flat from two years ago. So neither was a disaster, and there were chances to make good gains in both.
Worth a check, then, to see what he’s teasing this time? Why not?
The basic pitch is the same — that he’s looking for “x-factors” that will help you discover the “next Apple” while it’s still a penny stock, including good management, a hot social or economic trend, and takeover potential. And as he did a couple years ago, he’s teasing three “all-stars” in Penny Stock land that he thinks are “undiscovered stocks that could explode this year.”
Shall we jump right to the clues?
“PENNY STOCK ALL-STAR #1
“The Next Coca-Cola?
“Last year, Coke sold nearly $48 billion worth of drinks, and raked in nearly $8 billion in profits. Despite the success, consumers are drinking less soda these days. In fact, a major paper reported that “sales of carbonated soft drinks fell 1.2% last year…”
“Consumers are becoming more health conscious, and looking for lower calorie natural drinks. It’s an opportunity for an enterprising beverage manufacturer we’ve uncovered.
“The company’s core products are a line of 24 natural beverages sold throughout the US, Canada, Europe, and Asia. What sets this company apart is every product is made with all-natural ingredients and crafted with care. Products are sold primarily through 14,000 supermarkets and natural food stores. You’ll find their products in Kroger, Costco, Whole Foods Market, Trader Joe’s, and Sprouts just to name a few.
“Company revenue has doubled over the past three years thanks to rising demand… and losses are quickly evaporating. Management expects sales growth to accelerate going forward. Branded products sales are rising. Distribution is expanding and new products are taking off. Best of all, their private label business is gaining traction. It’s a rapid growth story in a huge market!”
Irregulars Quick Take
Paid members get a quick summary of the stocks teased and our thoughts here. Join as a Stock Gumshoe Irregular today (already a member? log in at top right)
This is a stock we’ve thought about before here at Stock Gumshoe — I covered them a while back when I was mentioning some potential stocks in the natural soda space, and our contributor Myron Martin featured them as a favorite idea in one of his columns for the Irregulars a few months ago. This is Reed’s (REED), the natural soda company whose primary products are Reed’s Ginger Ale and Virgil’s Root Beer, both natural sodas that are actually brewed. And I kind of like them, personally.
This is a very, very small company that’s trying to get up to scale by producing private label natural sodas for big chain supermarkets and then, once their foot is in the door, trying to sell their premium Reed’s and Virgil’s products (and a few others, including China Cola and the Harry Potter-inspired Butterscotch Beer). In my experience, I generally see them in Whole Foods and Trader Joe’s and in small local natural stores and coffee shops, but they’re not featured heavily in big supermarkets or in the places where soda consumption is highest (like fast food restaurants).
They are not profitable yet, but they’re pretty close to break-even — the revenue growth and volume growth have been solid, both at or near 20% lately (and close to that level for quite a while), and they’ve been pushing up against production capacity for their core products — in the last quarter they said they would have posted a profit if not for a substantial loss on a private label contract. There’s one analyst covering the stock, but I have no idea how current their opinion is — they list a $2.50 price target and predict profitability next year, but when there’s only one analyst on a stock you have to look at their numbers even more skeptically than you do an average analyst prediction.
REED is not in a real cash crunch, since they have enough to get through another few quarters at this “near break-even” level, and they can probably borrow if they need to, but neither are they super-flush with cash. It seems likely that if reaching capacity on their core products was a limiting factor this past quarter, they’ll probably have to expand to continue the growth trajectory. They’ve raised cash through private placements pretty much every other year since going public in 2006, so presumably they’d continue to do that and sell stock if they need to. That might be an opportunity for the stock to dip a bit, but these have generally not been huge capital raises in the past so it might not have a dramatic impact if it happens. Their founder and CEO does have a large stake in the company, so hopefully that’s a limiting factor on dilutive offerings.
I like the growth, I like the products, they’re positioning themselves well as a healthy soda alternative and, to some extent, as a nutraceutical like POM Wonderful with the ginger angle and their Kombucha product, and they already have good brand recognition and excellent distribution in their core natural foods stores market. The next leg of growth will probably have to come from pushing more volume through the natural foods channel or getting meaningful sales in traditional supermarkets (they’re on track to get this moving, but it’s still early days with just a few supermarket chains). I have not researched the company very fully, but it strikes me that they’re at the point where a substantial investment in capacity and marketing could have a big impact — which makes me wonder whether they’ll be the next natural drink company to get a big non-control investment from (or be acquired by) Coke or Pepsi (like Honest Tea, Odwalla, Fuze, Naked Drinks, Snapple etc.). If they stay independent, there’s a very good chance they’ll be profitable next year and they should continue to have a nice runway for double-digit revenue growth even without any real explosion in marketing spending, but — as we learned in their last quarter — they’re still small enough to be easily derailed by the whims of one big customer or any other glitch in the process.
Hoe about another one?
“PENNY STOCK ALL-STAR #2
“The Next Electronic Arts?
“The video game industry has grown into a $65 billion a year global industry. According to one market researcher, the industry’s expected to reach a whopping $86 billion by 2016. That’s a 32% increase in just three years!
“One small player we’ve uncovered is quickly becoming a leading provider of accessories for all major video game platforms, the personal computer, and even the Mac. In addition, it makes accessories for the iPod and other audio devices. The company’s products are sold all over US, Europe, and Canada, through retail giants like Amazon, Best Buy, GameStop, Target, Toys “R” Us, and Wal-Mart.
“With the release of next generation video game consoles imminent, it’s a catalyst for the company products. The arrival of new systems is usually accompanied by consumers purchasing a basket full of new accessories to improve and enhance their gaming experience. This company is in the cat-bird seat to profit from a massive new growth cycle… and it should lead to nothing short of monster gains.”
This one we can’t be 100% certain of, but our “most likely” answer from the Mighty, Mighty Thinkolator is: Mad Catz Interactive (MCZ)
Mad Catz has been around for ages, and I see them mentioned by investors every now and again — this is another very small company, with a market cap now of about $50 million, and they’ve been profitable about half the time over the last decade or so. Their last really good year for profit and growth was back in 2011 when the stock peaked at about $2 (it’s around 85 cents now). The shares have generally bounced around for those ten years between 50 cents and $1.50 a share, so they’ve never been able to create a real compounding growth story — it seems like it’s been pretty short-lived spikes driven by one thing or another that have moved the shares, but it’s impressive that they’ve even been around this long. They essentially sell gaming accessories — headsets, keyboards, special controllers and the like — which is a market where there should be little to no competitive advantage for anyone. The stuff is cheap to make, it’s hard to differentiate it, and the core market of the really rabid gamers who don’t find stock equipment to be acceptable relatively small and probably pretty fickle. So the fact that they still exist is testament to the fact that they must be fairly nimble and they’re probably doing something right.
They appear to have no meaningful insider ownership, though there have been small insider buys in recent years. They have issued new stock over the years, but not a ridiculous amount, and they do also use short-term debt, which would likely make them worried if interest rates spike or they can’t roll over the debt, but, again, it’s not a huge amount — about $10 million. My sense from scanning their financials over the past decade is that they’re working pretty hard to tread water in a competitive industry — maybe they will get a boost from the next generation of gaming consoles, I don’t know … and my gaming credentials are pretty much limited to the occasional bout of Words with Friends or Candy Crush on my phone, so I should probably be asking a teenager about this one before I form an opinion.
Next?
“PENNY STOCK ALL-STAR #3
“The Next Stericycle?
“As the US population ages, ongoing medical care will continue growing and expanding… and that means the amount of medical waste generated in this country will increase exponentially. We’ve found a company ready to solve this growing problem and make a mint from it too!
“The company we’ve uncovered is a full-service provider of cost-effective medical waste management services. It provides solutions for the proper treatment of hypodermic needles and unused consumer medications. And it serves customers in multiple markets, including home health care, retail clinics, immunizing pharmacies, drug manufacturers, professional offices, hospitality, government, consumers, commercial, industrial, and agricultural.
“The company has several competitive advantages to help it grow and capture market share… but they’re too detailed to address here. The key is the company’s proven business model is highly scalable, and profits are poised to jump as new customers are added. The experienced management team is committed to the growth of the company, and we’re sure to see the stock grow too!”
Again, that’s not really enough clues to be 100% certain — but the Thinkolator points us to a stock I’ve suggested (and then unsuggested) in the past, Sharps Compliance (SMED), a $41 million company that does indeed provide medical waste management services — and they do specifically mention those precise end markets in their filings, including the relatively esoteric “agriculture” market (though it’s a meaningful market, if you think about it — most livestock farmers inject their charges with all kinds of stuff to keep them plump and healthy, and you’ve got to do something with those needles).
Sharps Compliance was a growth darling when I first wrote about them a few years ago, they had gotten into the government buying system and had a couple foundational orders that dramatically boosted their revenues, getting them the attention of Louis Navellier, who teased the stock and brought it to my attention. Unfortunately, it so happens that those orders didn’t recur at the level they were hoping and the growth disappeared almost instantly — they doubled revenues in 2010 from $20 million to about $39 million and posted a nice profit and hope for the future, but then in 2011 the revenues were back down to $19 million and they’ve been on a much more tepid and unprofitable growth path since then.
The company essentially sells the little disposal packs that you see in restrooms or hospitals, places to dispose of needles, and the product comes with the disposal service, so they just get packaged up and mailed back to them for incineration (or whatever). They also have a similar product for disposing of unwanted medications, which is something that’s growing in the public consciousness but is still a much smaller business than sharps disposal. I have not looked at the company in detail since writing them off after their burst of growth failed to be maintained, but my assessment then was that they were a midget among giants (Stericycle and all the big medical distributors, all of whom are either in this business, or could enter it in the blink of an eye), and that their product was not differentiated enough to give them any advantage. I could certainly be wrong, and I haven’t looked to see if they have a bunch of new orders or products, but SMED is our best answer for this “all-star” penny stock in the medical waste business, and you can researchify that one on your own and holler if you find it exciting.
So … any favorites in that bunch? Personally, I’d probably rank them in the order given, and REED seems the one with the best chance of building a real sustainable brand, but they’re all very small and are in competitive businesses … it’s your money, so what do you think? Let us know with a comment below.
Surprised to see GRLT pop today - how many times is this ticker going to be promoted? This one is tough to trade - large bid/ask spread most of the time and extremely volatile. I actually hold 24K worthless restricted shares in this one from the stock dividend - now I have to look at those in my account summary for the next year:
The HIGHEST GAINING Penny Stock
for Monday, September 23, 2013 is...
454 emails were received and added to the Rumble today. After careful consideration of the end of day data, looking at BOTH dollar volume and percentage gain, we have made a decision on the winning penny stock of the day.
The winner for the day is:
GRILLiT, Inc. (GRLT)
Last Trade: $1.7500
Price changed: $0.4500
Percentage Gain: 34.62 %
Last Close: $1.3000
Volume: 125,108
Estimated Dollar Volume: $218,939.00
Congrats to Top Stock Pickers: Penny Stock Divas, Market Wire Press,.
You are the King of the Stock Pickers today!
About GRILLiT, Inc. (GRLT)
Grillit Inc, formerly Holdings Energy Inc., is a public corporation that discovers, invests and or acquires development-stage with solutions, clean technologies and eco-friendly products that serve the global alternative energy sector. The Company was formed to develop and engage in operations and management of digital wireless data communications services of 220 megahertz digital wireless data communications. In April 2013, the Company acquired Healthy & Tasty Ventures LLC.
*************************
HONORABLE MENTIONS:
HIGHEST % GAIN:
COMPANY:GRLT
% GAIN: 34.62%
STOCK PICKER: Penny Stock Divas, Market Wire Press,
I am guessing they are talking about NNRX below - we shall soon seen. It would be nice if I was wrong and we had 2 promo stocks to start playing:
Penny Stock Experts Blog - blog.todayspickis.com
Our New Profiled Pick TBA Tomorrow Morning 9:25AM
SIGN UP FOR OUR FREE PENNY STOCK NEWSLETTER ABOVE TO RECEIVE THE HOTTEST PENNY STOCK ALERTS BEFORE ANYONE ELSE!
Hi Everyone & Welcome New Subscribers,
There is no watch list with multiple stocks on watch for tomorrow, but for a good reason - we've found ONE stock that deserves your undivided attention the rest of this week.
After much anticipation, we are happy to announce our new profiled pick is coming tomorrow morning at 9:25AM.
(If you're signed up for our e-mail alerts, you'll get the alert up to 20 minutes sooner)
In the past, our profiled picks have seen gains as high as 1500% from our intitial alert price, and we could easily see this pick producing triple digit gains from our alert.
The Company has announced some exciting progress over the past week that makes it worthy of all of our subscribers attention tomorrow morning and will likely catch a lot more outside attention after.
This pick has an eerily similar trading pattern to some of our biggest alerts like TALK or GNIN, both of which traded near $1.00 at the time of our alert and saw triple digit gains!
We have spent weeks to find something this special for all of you and we are extremely confident in the potential upside of our new pick at current price levels.
One thing is for sure - our new pick is not the pick you want to miss!
Those signed up to our e-mail list will get our new pick before the market opens, but for those of you who only follow our blog, it will be available here by 9:25AM and on our home page thereafter.
Happy Trading!
The Penny Stock Experts Team at Todayspickis.com
VPIG should bounce - just a matter of timing it. The PR below had me laughing - look at the time of the release and the action today and you will notice it seems to have had the opposite of the intended effect:
Virtual Piggy Comments on Recent Internet Blogs and Articles
Print
Alert
Virtual Piggy, Inc. (OTCBB:VPIG)
Intraday Stock Chart
Today : Tuesday 24 September 2013
Click Here for more Virtual Piggy, Inc. Charts.
Virtual Piggy, Inc. (OTCBB:VPIG), an innovator in safe youth payments, today commented on content on certain “investor-targeted” internet blogs and sites.
Virtual Piggy has been the subject of recent articles on certain investor websites that present negative information regarding some of our shareholders. These blogs and articles invite the reader to infer that one or more of those investors control Virtual Piggy, Inc., or that the operations or management of the Company are somehow impugned as a consequence of their stock ownership. Virtual Piggy is managed solely by its Board of Directors and management team, whose experience and integrity guide the Company on a daily basis. The Company is aware that some of the authors are people (or firms) who hold a short position in Virtual Piggy common stock. The Company recommends that investors view with a degree of skepticism all articles regarding the Company, both positive and negative; and refer to Virtual Piggy’s public reports for definitive information regarding the Company.
The Company believes that it is in its best interests to remain focused on building the business, rather than debating or responding to individual internet websites and bloggers, whose goals may not be transparent. Virtual Piggy will continue its practice of regularly updating the public on its progress.
For information about Virtual Piggy visit www.VirtualPiggy.com
I bailed on MEDA at open when it looked shady (I never hold a promo stock if it can't pull of a Monday morning gapup). Just checked it EOD - it tanked further than I thought it would on high volume. This one could give a bounce tomorrow. I will likely not bother with it unless we get a dip and rip.
I hold a bit of this one also - another good day today. I just hold now with a rolling stop.
SRPT moving nice (on the high short interest list posted below)
I expect it will follow the path of TALK, but we shall see